Baxter Hit With Investor Class Actions in Illinois Over Novum IQ Pump Safety Disclosures

Overview

• Complaints in the U.S. District Court for the Northern District of Illinois target investors who bought Baxter shares from February 23, 2022 through July 30, 2025, with a December 15, 2025 deadline to seek lead-plaintiff status.
• Plaintiffs allege Novum IQ large-volume pumps had systemic defects causing underinfusion, overinfusion and non-delivery, and that Baxter’s customer alerts were inadequate to remedy design flaws.
• An April whistleblower report preceded Baxter warnings, and a July 14 letter disclosed 79 serious-injury reports and two patient deaths linked to the device.
• Baxter said on July 31 it would voluntarily and temporarily pause Novum LVP shipments and installations without a restart date, and the stock fell about 22% that day.
• The suits contend executives misrepresented safety, rollout progress and sales prospects, and note the company offered its older Spectrum pump as an interim alternative.